Pharmakogenetik der oralen Antikoagulation mit Cumarinen |
| |
Authors: | Prof Dr J Oldenburg S Rost H Seidel M Watzka CR Müller-Reible |
| |
Institution: | 1. Institut für Experimentelle H?matologie und Transfusionsmedizin, Universit?tsklinik Bonn, Sigmund-Freud-Stra?e 25, 53127, Bonn, Deutschland 2. Institut für Humangenetik, Biozentrum, Universit?t Würzburg, Würzburg, Deutschland
|
| |
Abstract: | The recent identification of VKORC1 has made important contributions to our understanding of the vitamin K cycle. The VKORC1 enzyme was shown to be the molecular target of coumarin drugs. Mutations and polymorphisms in coding and noncoding regions of the VKORC1 gene have been shown to cause both a partial to total coumarin resistance and coumarin sensitivity. Availability of molecular diagnostics (VKORC1, CYP2C9) and drug monitoring by HCPLC (determination of coumarin, vitamin K, and vitamin K epoxide levels) is helpful for detecting hereditary and acquired factors influencing coumarin therapy. In the future, these tools may be instrumental in designing individualized oral anticoagulation therapy regimens. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|